MK-1084 Single and Multiple Dose Healthy Participant Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507529-41-00

Acronym

MK-1084-005

Enrollment

Registered

2023-10-25

Start date

2023-11-07

Completion date

2024-07-12

Last updated

2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor cancer and lung cancer

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026